Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation

被引：10

作者：

Mohty, Mohamad ^{[1
]}

Malard, Florent

机构：

[1] Hop St Antoine, Paris, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 36期

关键词：

MATCHED UNRELATED DONORS; ANTI-THYMOCYTE GLOBULIN; OPEN-LABEL; HEMATOLOGICAL MALIGNANCIES; PHASE-3; TRIAL; MULTICENTER; MARROW; PREVENTION; MORTALITY; OUTCOMES;

D O I：

10.1200/JCO.2017.76.0512

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：3993 / +

页数：4

共 23 条

[1] Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis [J].

Admiraal, Rick ;

Nierkens, Stefan ;

de Witte, Moniek A. ;

Petersen, Eefke J. ;

Fleurke, Ger-jan ;

Verrest, Luka ;

Belitser, Svetlana V. ;

Bredius, Robbert G. M. ;

Raymakers, Reinier A. P. ;

Knibbe, Catherijne A. J. ;

Minnema, Monique C. ;

van Kesteren, Charlotte ;

Kuball, Jurgen ;

Boelens, Jaap J. .

LANCET HAEMATOLOGY, 2017, 4 (04) :E183-E191

[2] Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors [J].

Anasetti, Claudio ;

Logan, Brent R. ;

Lee, Stephanie J. ;

Waller, Edmund K. ;

Weisdorf, Daniel J. ;

Wingard, John R. ;

Cutler, Corey S. ;

Westervelt, Peter ;

Woolfrey, Ann ;

Couban, Stephen ;

Ehninger, Gerhard ;

Johnston, Laura ;

Maziarz, Richard T. ;

Pulsipher, Michael A. ;

Porter, David L. ;

Mineishi, Shin ;

McCarty, John M. ;

Khan, Shakila P. ;

Anderlini, Paolo ;

Bensinger, William I. ;

Leitman, Susan F. ;

Rowley, Scott D. ;

Bredeson, Christopher ;

Carter, Shelly L. ;

Horowitz, Mary M. ;

Confer, Dennis L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16) :1487-1496

[3] Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research [J].

Arai, Sally ;

Arora, Mukta ;

Wang, Tao ;

Spellman, Stephen R. ;

He, Wensheng ;

Courie, Daniel R. ;

Urbano-Ispizua, Alvaro ;

Cutler, Corey S. ;

Bacigalupo, Andrea A. ;

Battiwallaw, Minoo ;

Flowers, Mary E. ;

Juckett, Mark B. ;

Lee, Stephanie J. ;

Loren, Alison W. ;

Klumpp, Thomas R. ;

Prockup, Susan E. ;

Ringden, Olle E. T. H. ;

Savani, Bipin N. ;

Socie, Gerard ;

Schultz, Kirk R. ;

Spitzer, Thomas ;

Teshima, Takanori ;

Bredeson, Christopher N. ;

Jacobsohn, David A. ;

Hayashi, Robert J. ;

Drobyski, William R. ;

Frangoul, Haydar A. ;

Akpek, Gorgiin ;

Ho, Vincent T. ;

Lewis, Victor A. ;

Gale, Robert Peter ;

Koreth, John ;

Chao, Nelson J. ;

Aljurf, Mahmoud D. ;

Cooper, Brenda W. ;

Laughlin, Mary J. ;

Hsu, Jack W. ;

Hematti, Peiman ;

Verdonck, Leo F. ;

Solh, Melhelm M. ;

Norkin, Maxim ;

Reddy, Vijay ;

Perez-Simon, Jose A. ;

Khera, Nandita ;

Lewis, Ian D. ;

Atsuta, Yoshiko ;

Olsson, Richard F. ;

Saber, Wael ;

Waller, Edmund K. ;

Blaise, Didier .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) :266-274

[4] Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation [J].

Ayuk, Francis ;

Diyachenko, Galina ;

Zabelina, Tatjawa ;

Wolschke, Christine ;

Fehse, Boris ;

Bacher, Ulrike ;

Erttmann, Rudolf ;

Kroeger, Nicolaus ;

Zander, Axel R. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (08) :913-919

[5] Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation [J].

Bacigalupo, A ;

Lamparelli, T ;

Barisione, G ;

Bruzzi, P ;

Guidi, S ;

Alessandrino, PE ;

di Bartolomeo, P ;

Oneto, R ;

Bruno, B ;

Sacchi, N ;

van Lint, MT ;

Bosi, A .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (05) :560-565

[6] Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) [J].

Bacigalupo, A ;

Lamparelli, T ;

Bruzzi, P ;

Guidi, S ;

Alessandrino, PE ;

di Bartolomeo, P ;

Oneto, R ;

Bruno, B ;

Barbanti, M ;

Sacchi, N ;

Van Lint, MT ;

Bosi, A .

BLOOD, 2001, 98 (10) :2942-2947

[7] What do we need to know about allogeneic hematopoietic stem cell transplant survivors? [J].

Clark, C. A. ;

Savani, M. ;

Mohty, M. ;

Savani, B. N. .

BONE MARROW TRANSPLANTATION, 2016, 51 (08) :1025-1031

[8] Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT [J].

Cutler, Corey ;

Logan, Brent ;

Nakamura, Ryotaro ;

Johnston, Laura ;

Choi, Sung ;

Porter, David ;

Hogan, William J. ;

Pasquini, Marcelo ;

MacMillan, Margaret L. ;

Hsu, Jack W. ;

Waller, Edmund K. ;

Grupp, Stephan ;

McCarthy, Philip ;

Wu, Juan ;

Hu, Zhen-Huan ;

Carter, Shelly L. ;

Horowitz, Mary M. ;

Antin, Joseph H. .

BLOOD, 2014, 124 (08) :1372-1377

[9] Graft-versus-host disease [J].

Ferrara, James L. M. ;

Levine, John E. ;

Reddy, Pavan ;

Holler, Ernst .

LANCET, 2009, 373 (9674) :1550-1561

[10] Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial [J].

Finke, Juergen ;

Schmoor, Claudia ;

Bethge, Wolfgang Andreas ;

Ottinger, Hellmut ;

Stelljes, Matthias ;

Volin, Liisa ;

Heim, Dominik ;

Bertz, Hartmut ;

Grishina, Olga ;

Socie, Gerard .

LANCET HAEMATOLOGY, 2017, 4 (06) :E293-E301

← 1 2 3 →